
The Food and Drug Administration on Friday approved the first at-home test to screen for cervical cancer, Teal Health, which makes the test kit, said. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading. Currently, cervical cancer screening is done in a doctor’s office during a pelvic exam, a process some women find uncomfortable and even painful. Some patients don’t get screened for cervical cancer because they don’t want a pelvic exam, said Dr.
Main Idea: The FDA approved Teal Health’s at-home HPV test, giving people a new way to screen for cervical cancer without a pelvic exam.
Key Points:
Some people may still face follow-up office visits, and the test’s price and insurance coverage are not yet fully clear.
FDA approval of Teal Health’s at-home HPV test could make cervical cancer screening easier and reach more women who avoid pelvic exams or live far from care.
Rate how each entity in this article affected the American people.
Maker of the newly approved at-home test kit and a main subject of the article.
Central regulator that approved the first at-home HPV test.
Named physician quoted about screening barriers and early studies validating the test.
Named physician quoted on access benefits and remaining uncertainties.
Named physician quoted on the importance of cervical cancer screening.
CEO of Teal Health quoted on pricing and insurance coverage.
Healthcare institution where Dr. Jessica Kiley serves and is referenced in the discussion.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentHealthcare institution associated with Dr. Emeline Aviki.
Cited for its endorsement relevant to expected insurance coverage.
Healthcare institution associated with Dr. George Sawaya.
Cited publication for a report on rural cervical cancer disparities.